![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial (ecancer) View |
![]() |
Obinutuzumab Extends Remission Time in Rituximab-Refractory iNHL (American Society of Hematology) View |
![]() |
Obinutuzumab bests rituximab for PFS in follicular lymphoma (MDedge: news and insights for busy physicians) View |
![]() |
Overview of the GALLIUM study (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Debate: Is obinutuzumab superior to rituximab in lymphoma - No (HMP Education) View |
![]() |
Debate: Best upfront therapy for advanced follicular lymphoma - Obinutuzumab-based therapy (HMP Education) View |
![]() |
Debate: Is obinutuzumab superior to rituximab in lymphoma - Yes (HMP Education) View |
![]() |
ASCO 2015: Obinutuzumab Doubles Remission Duration in Relapsed, Indolent Non-Hodgkin Lymphoma (EMJ) View |
![]() |
Complete Response at 30 Months: A Surrogate for PFS in First-Line Follicular Lymphoma (American Society of Hematology) View |
![]() |
Intravenous or subcutaenous rituximab for FL in the SABRINA study (ecancer) View |